| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human multiple inositol-polyphosphate phosphatase 1 (MINPP1), transcript variant 2. from ORIGENE TECHNOLOGIES | TP329866 | 20 ug | ORIGENE TECHNOLOGIES |
| Human multiple inositol-polyphosphate phosphatase 1 (MINPP1), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP710176 | 20 ug | ORIGENE TECHNOLOGIES |
| Human Multiple urinary system sites; Carcinoma of bladder, papillary transitional cell from ORIGENE TECHNOLOGIES | CS808649 | 5x5um | ORIGENE TECHNOLOGIES |
| Nuclear assembly factor 1 homolog (S. cerevisiae) (NAF1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY408651 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear autoantigenic sperm protein (histone-binding) (NASP), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400884 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear cap binding protein subunit 1, 80kDa (NCBP1) from ORIGENE TECHNOLOGIES | LY419301 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear cap binding protein subunit 2, 20kDa (NCBP2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402134 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1) from ORIGENE TECHNOLOGIES | LY411597 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear distribution gene C homolog (A. nidulans) (NUDC) from ORIGENE TECHNOLOGIES | LY401974 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor (erythroid-derived 2), 45kDa (NFE2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401856 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor (erythroid-derived 2), 45kDa (NFE2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427772 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor I/A (NFIA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY427477 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor I/A (NFIA), transcript variant 2 from ORIGENE TECHNOLOGIES | LY417202 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor I/A (NFIA), transcript variant 3 from ORIGENE TECHNOLOGIES | LY428916 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor I/B (NFIB) from ORIGENE TECHNOLOGIES | LY417203 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor I/B (NFIB), transcript variant 1 from ORIGENE TECHNOLOGIES | LY434274 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor I/B (NFIB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY434239 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor, interleukin 3 regulated (NFIL3) from ORIGENE TECHNOLOGIES | LY401653 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor I/X (CCAAT-binding transcription factor) (NFIX) from ORIGENE TECHNOLOGIES | LY419287 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein (NFATC2IP) from ORIGENE TECHNOLOGIES | LY409942 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATC1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403545 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATC1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY403544 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 (NFATC2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415797 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 (NFATC2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406687 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 (NFATC3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY406697 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 (NFATC3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY417912 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 (NFATC3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429207 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 (NFATC4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY427771 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of activated T-cells 5, tonicity-responsive (NFAT5), transcript variant 6 from ORIGENE TECHNOLOGIES | LY426386 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (NFKBIB), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419285 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA) from ORIGENE TECHNOLOGIES | LY412432 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (NFKBIB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY424220 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (NFKBIB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425058 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta (NFKBID) from ORIGENE TECHNOLOGIES | LY408361 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2 (NFKBIL2) from ORIGENE TECHNOLOGIES | LY415543 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 (NFKBIL1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417580 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 (NFKBIL1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY428610 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta (NFKBIZ), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410530 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta (NFKBIZ), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423589 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418264 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) (NFKB2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400895 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) (NFKB2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY421444 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear factor related to kappaB binding protein (NFRKB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY416826 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear fragile X mental retardation protein interacting protein 1 (NUFIP1) from ORIGENE TECHNOLOGIES | LY415803 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear fragile X mental retardation protein interacting protein 2 (NUFIP2) from ORIGENE TECHNOLOGIES | LY412327 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear import 7 homolog (S. cerevisiae) (NIP7) from ORIGENE TECHNOLOGIES | LY414162 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear mitotic apparatus protein 1 (NUMA1) from ORIGENE TECHNOLOGIES | LY416823 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear prelamin A recognition factor-like (NARFL) from ORIGENE TECHNOLOGIES | LY411641 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear prelamin A recognition factor (NARF), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415832 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear prelamin A recognition factor (NARF), transcript variant 3 from ORIGENE TECHNOLOGIES | LY422003 | 100 ug | ORIGENE TECHNOLOGIES |